Evolution of the Average Target: Rollins, Inc.

Evolution of the Target Price: Rollins, Inc.

Changes in Analyst Recommendations: Rollins, Inc.

4f778b5bd39f72e95dce778abcb5.m6iMzeR4evGRk-K_PIqVw10h_ak28ZlU774UCzupzhI._tv9v48bAJXW-ZHbV8XamQpNyesPuapmov8gYH__-0X_3rT8hQkyksvQjQ~619ac0c240d5efe5e3712bf01d526504
02-13 BNP Paribas Adjusts Price Target on Rollins to $63 From $65, Maintains Neutral Rating MT
02-12 Goldman Sachs Adjusts Price Target on Rollins to $66 From $64, Maintains Buy Rating MT
02-12 RBC Cuts Price Target on Rollins to $67 From $70, Keeps Outperform Rating MT
02-12 Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap… Zonebourse
02-12 Wells Fargo Downgrades Rollins to Equalweight From Overweight, Adjusts Price Target to $56 From $68 MT
01-21 UBS Adjusts Rollins Price Target to $65 From $61, Maintains Neutral Rating MT
01-14 Wells Fargo Adjusts Rollins Price Target to $68 From $65, Maintains Overweight Rating MT
01-06 BNP Paribas Exane Initiates Rollins at Neutral With $65 Price Target MT
12-23 RBC Raises Price Target on Rollins to $70 From $62, Keeps Outperform Rating MT
12-17 Morgan Stanley Upgrades Rollins to Overweight, Price Target is $72 MT
12-05 Rollins Shares Gain After Barclays Upgrade MT
12-05 Analyst recommendations: Humana, Newmont, Robert Half, Apple, Macy's… Zonebourse
12-05 Barclays Upgrades Rollins to Overweight From Equalweight, Adjusts Price Target to $72 From $60 MT
11-12 Rothschild & Co Redburn Adjusts Price Target on Rollins to $51.90 From $47, Maintains Neutral Rating MT
11-12 Bernstein Initiates Rollins at Outperform With $70 Price Target MT
11-03 Jefferies & Co Adjusts Rollins Price Target to $66 From $65 MT
31/10/25 Canaccord Genuity Adjusts Rollins Price Target to $55 From $50 MT
31/10/25 Wells Fargo Adjusts Rollins Price Target to $65 From $63 MT
31/10/25 Goldman Sachs Adjusts Rollins Price Target to $64 From $62 MT
28/10/25 Wells Fargo Adjusts Price Target on Rollins to $63 From $65, Maintains Overweight Rating MT
30/09/25 Rollins Poised to Reiterate 2025 Guidance During Quarterly Earnings, RBC Says MT
26/09/25 JPMorgan Initiates Rollins at Overweight With $70 Price Target MT
25/07/25 UBS Adjusts Rollins Price Target to $61 From $59, Maintains Neutral Rating MT
25/07/25 Barclays Adjusts Price Target on Rollins to $60 From $55, Maintains Equalweight Rating MT
25/07/25 Piper Sandler Adjusts Price Target on Rollins to $72 From $70, Maintains Overweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+9.23%
+6.51%
Average +7.87%
Weighted average by Cap. +8.25%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
58.28USD
Average target price
63.66USD
Spread / Average Target
+9.23%
High Price Target
72.00USD
Spread / Highest target
+23.54%
Low Price Target
50.00USD
Spread / Lowest Target
-14.21%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BNP Paribas
Goldman Sachs
RBC Capital Markets
Wells Fargo Securities
UBS
BNP Paribas Exane
Morgan Stanley
Barclays
Bernstein
Rothschild & Co Redburn
Jefferies & Co.
Canaccord Genuity
JPMorgan Chase
Piper Sandler
Argus
Redburn Atlantic
CFRA
Stifel Nicolaus
BofA Securities
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
58.28USD
Average target price
63.66USD
Spread / Average Target
+9.23%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ROL Stock
  4. Consensus Rollins, Inc.